Norbert W. Bischofberger
2013
In 2013, Norbert W. Bischofberger earned a total compensation of $5.6M as Executive Vice President, Research and Development and Chief Scientific Officer at Gilead Sciences, a 4% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $1,068,000 |
|---|---|
| Option Awards | $1,800,054 |
| Salary | $884,175 |
| Stock Awards | $1,740,781 |
| Other | $95,378 |
| Total | $5,588,388 |
Bischofberger received $1.8M in option awards, accounting for 32% of the total pay in 2013.
Bischofberger also received $1.1M in non-equity incentive plan, $884.2K in salary, $1.7M in stock awards and $95.4K in other compensation.
Rankings
In 2013, Norbert W. Bischofberger's compensation ranked 1,082nd out of 12,286 executives tracked by ExecPay. In other words, Bischofberger earned more than 91.2% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 1,082 out of 12,286 | 91st |
Division Manufacturing | 349 out of 4,612 | 92nd |
Major group Chemicals And Allied Products | 93 out of 1,466 | 94th |
Industry group Drugs | 58 out of 1,160 | 95th |
Industry Biological Products, Except Diagnostic Substances | 6 out of 200 | 97th |
Source: SEC filing on March 28, 2016.
Bischofberger's colleagues
We found four more compensation records of executives who worked with Norbert W. Bischofberger at Gilead Sciences in 2013.